NEWS AND ANNOUNCEMENTS
Potential SMA Therapy Ready for a First Clinical Test — Jan 23, 2016 9:42:00 PM
In Spinal Muscular Atrophy, Vascular System May Play a Key Role — Jan 23, 2016 9:26:46 PM
Impaired Mitochondrial Dynamics Play Role in SMA Pathology — Jan 23, 2016 9:17:43 PM
Spinal Muscular Atrophy Study Points to Blood Vessel Defects — Jan 23, 2016 9:10:37 PM
Key SMA Patient Trial of Skeletal Muscle Activator Getting Underway — Jan 23, 2016 9:04:07 PM
Isis Pharmaceuticals Announces Open-Label Extension Study SHINE in Pediatric SMA Patients — Jan 23, 2016 8:57:13 PM
Candidate Drug Provides Benefit in Spinal Muscular Atrophy Animal Models — Jun 5, 2013 11:22:02 PM
A new approach to spinal muscular atrophy? — Jun 5, 2013 11:16:30 PM
SMA: Trial Tests Antisense Therapy in Infants — Jun 4, 2013 3:26:38 AM
A case of spinal muscular atrophy type 0 in Japan. — May 17, 2013 2:56:00 PM
Repligen Initiates Phase 1b Trial of RG3039 for Spinal Muscular Atrophy Licensed from Families of SMA. — May 17, 2013 2:54:57 PM
President Obama Signs Into Law a Bill to Expedite FDA Approval of Drugs for Rare Diseases. — May 17, 2013 2:53:48 PM
Hypoxia is a modifier of SMN2 splicing and disease severity in a severe SMA mouse model. — May 17, 2013 2:52:47 PM
Research Suggests New Cause to Blame for Spinal Muscular Atrophy — May 17, 2013 2:51:38 PM
Families of Spinal Muscular Atrophy Announces $700,000 Funding for Novel Drug Program at Newly Created California Institute for Biomedical Research — May 17, 2013 2:46:39 PM
Scientists measure communication between stem cell-derived motor neurons and muscle cells — May 17, 2013 2:45:28 PM
Possible Cause of Movement Defects in Spinal Muscular Atrophy Identified — May 17, 2013 2:44:14 PM
Repligen Reports Positive Results from Phase 1 Clinical Trial of RG3039 for Spinal Muscular Atrophy — May 17, 2013 2:43:03 PM
NIH Provides Congress an Overview of the Federal Government’s Spinal Muscular Atrophy Research Activities. — May 17, 2013 2:41:19 PM
SMA News 2011 — May 17, 2013 2:36:51 PM
SMA News 2010 — May 17, 2013 2:34:25 PM
SMA News 2009 — May 17, 2013 2:31:33 PM
Hans Keirstead: Developing therapies based on embryonic stem cells — May 17, 2013 2:26:08 PM
Valproic Acid blocks Excitability in SMA Type I Mouse Motoneurons. — May 17, 2013 2:24:29 PM
2009 Families of SMA Conference — May 17, 2013 2:22:48 PM